Statement Of Cash Flows [Abstract]

Biotage - Filing #678905

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments to reconcile profit (loss) other than changes in working capital
163,000,000 SEK
84,000,000 SEK
Cash flows from (used in) operations before changes in working capital
370,000,000 SEK
380,000,000 SEK
Increase (decrease) in working capital
86,000,000 SEK
39,000,000 SEK
Adjustments for decrease (increase) in trade and other receivables
97,000,000 SEK
45,000,000 SEK
Adjustments for increase (decrease) in trade and other payables
31,000,000 SEK
51,000,000 SEK
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
1 49 SEK
101,000,000 SEK
Income taxes paid, classified as operating activities
96,000,000 SEK
52,000,000 SEK
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
10 6 SEK
102,000,000 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.